BYLUTA 50 (Bicalutamide (50mg))

Byluta 50 Tablet is prescribed for the management of prostate cancer and may also be utilized for other medical issues as identified by a healthcare professional. This medication functions by inhibiting the action of male hormones such as testosterone, which can influence the growth of certain cancer cells. When taking Byluta 50 Tablet, it can be consumed either on an empty stomach or with food; however, consistency in the timing of the doses is recommended—ideally at the same time each day. The prescribing physician will determine the appropriate dosage and frequency of administration based on the specific condition being treated, and adjustments may be made over time. It is crucial to adhere strictly to the prescribed regimen, as misuse or an overdose can lead to severe adverse effects. Patients may need to wait several weeks or months to experience the full benefits of this therapy, and discontinuation of the medication should only occur under medical guidance. A frequent side effect of this medication is anemia, associated with a reduced red blood cell count. Other significant adverse reactions that warrant immediate medical attention include jaundice, appetite loss, difficulty breathing, stomach pain, dark-colored urine, and skin rashes. Blood tests for monitoring red blood cell levels and liver function are necessary throughout the treatment process. The medication can make skin more sensitive to sunlight, so precautions should be taken while outdoors. Prior to initiation of therapy, patients should disclose any history of diabetes, kidney or liver dysfunction, and all current medications to their healthcare provider. This medicine is contraindicated in pregnancy and breastfeeding, as it poses a risk to the fetus or infant. Effective contraception is advised for both partners during treatment. Regular monitoring of blood glucose may be requested during the course of therapy.